Renal toxicity of the antitumor drug N2-
โ
G. Raguenez-Viotte; C. Dadoun; P. Buchet; T. Ducastelle; J. P. Fillastre
๐
Article
๐
1988
๐
Springer-Verlag
๐
English
โ 550 KB
Celiptium (N2-methyl-9-hydroxy-ellipticinium) is an antitumoral agent used to treat bone metastases from breast carcinomas. This new drug appeared to be of great interest because of the absence of hepato-or myelotoxicity. Three different investigators recently mentioned cases of celiptium-induced re